SoftBank Group’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.8M | Hold |
6,541,190
| – | – | 0.02% | 25 |
|
|
2025
Q1 | $6.54M | Hold |
6,541,190
| – | – | 0.02% | 23 |
|
|
2024
Q4 | $69.3M | Sell |
6,541,190
-1,005,726
| -13% | -$10.7M | 0.3% | 12 |
|
|
2024
Q3 | $99.7M | Sell |
7,546,916
-100,000
| -1% | -$1.32M | 0.45% | 10 |
|
|
2024
Q2 | $75.2M | Hold |
7,646,916
| – | – | 0.38% | 10 |
|
|
2024
Q1 | $105M | Hold |
7,646,916
| – | – | 0.55% | 8 |
|
|
2023
Q4 | $130M | Hold |
7,646,916
| – | – | 0.7% | 8 |
|
|
2023
Q3 | $108M | Buy |
+7,646,916
| New | +$108M | 1.19% | 8 |
|